Cholesterol metabolism is pivotal to cellular homeostasis, hormones production, and membranes composition. Its dysregulation associates with malignant reprogramming and therapy resistance. Cholesterol is trafficked into the mitochondria for steroidogenesis by the transduceome protein complex, which assembles on the outer mitochondrial membrane (OMM). The highly conserved, cholesterol-binding, stress-reactive, 18kDa translocator protein (TSPO), is a key component of this complex. Here, we modulate TSPO to study the process of mitochondrial retrograde signalling with the nucleus, by dissecting the role played by cholesterol and its oxidized forms. Using confocal and ultrastructural imaging, we describe that TSPO enriched mitochondria, remodel around the nucleus, gathering in 
Introduction
Mitochondria actively take part in remodelling and reprogramming of mammalian cells. In response to stressors, either of endogenous or exogenous nature, they retro-communicate with the nucleus to induce wide-ranging cytoprotective effects that sustain proliferation and death evasion. This process, which goes under the name of mitochondrial retrograde response (MRR) and exploited in pathological settings, is driven by deregulation of Reactive Oxygen Species (ROS), Ca 2+ signalling and energy defects that promote nuclear stabilization of transcription factors (e.g. nuclear factor kappa-light-chain-enhancer of activated B cells, NF-kB), responsible to drive the metabolic rewiring and resistance mechanisms to therapy. In hormone-dependent tumours, such as those of the mammary gland, the therapeutic failure of therapy is now linked to alterations in the cholesterol metabolism 1, 2 . The 18kDa mitochondrial protein TSPO 3 , which trasnlocates cholesterol from the outer into the inner mitochondrial environment, is overexpressed in these pathologies which it might contribute by impacting their MRR 4,5 via core features of its recently enlighten molecular physiology 5 , 6 .
The retrograde (mitochondria to nucleus) communication 7 is indeed driven by mitochondrial dysfunction [8] [9] [10] [11] which associates with TSPO overexpression as this leads to intracellular redox-stress (ii), raised cytosolic Ca 2+ transients (iii), and organelle compartmentalization of cholesterol (iii). The metabolic rewiring 12 which is a key step in the cancerous transformation 13, 14 is therefore secondary to deregulated mitochondrial function. Cholesterol and cholesterol-derived intermediates have been instead recently highlighted as a determinant in the oncogenic reprogramming 1 . Metastatic, endocrine therapy breast cancer cells, isolated from patients, show increased expression of CYP19A1, a member of the cytochrome C p450 monooxygenase enzymes 2 , which catalyses the last steps of oestrogen synthesis from cholesterol. This prompted the curiosity for the contribution cholesterolassociated proteins such as TSPO could play in this process and how mitochondrial trafficking of cholesterol could influence the MRR. TSPO which localises on the Outer Mitochondrial Membrane (OMM) is detected at greater levels in the aggressive forms of the mammary lesions [15] [16] [17] , and besides taking part in the synthesis the steroids by shuttling cholesterol [18] [19] [20] into the mitochondria its also impairs mitophagy 21, 22 resulting in poor organelle respiration and handling of Ca 2+22,23 . Notably, TSPO is reported of anti-apoptotic activity 24 and its ligands tested as chemotherapy co-adjuvant 25 as well as PET-biomarkers of metastases 26, 27 ; however its role in the management of cholesterol and the MRR in the economy of cellular pathophysiology remains unexplored. Cholesterol synthesis inhibition improves mitochondrial driven apoptosis of cancer cells 28 but whether influences the efficacy of MRR is untested. The driving hypothesis for this work was therefore that in response to stressors cholesterol accumulates on the outer mitochondrial membrane (OMM)
via TSPO priming mitochondria retrograde communication with the nucleus via the formation of cholesterol-rich domains which facilitate stabilization of pro-survival transcription factors 29 .
Using a combination of imaging methods at cellular and ultrastructural level along with pioneering protocols of cholesterol dynamics analysis we are here detailing a molecular axis of communication between mitochondria and nucleus (i), provide evidences for hot-spots which link mitochondria with nucleus (ii) and to biochemically and pharmacologically control this route of signalling via the protein target TSPO (iii).
Results
The association between TSPO and NF-kB was initially corroborated in primary human samples of mammary gland tumours in which we observed a positive correlation between TSPO expression and the aggressiveness of the lesions (Figure 1 a, b) mirrored by the pattern of NF-κB 29, 30 accumulation in the nucleus (Figure 1d, e) . In agreement with this, transcriptomic analysis of >600 samples of breast cancer in the Cancer Genome Atlas In order to elucidate the nature of this oncogenic capacity we moved the analysis to cell lines of human breast cancer 15 and interrogated the biochemical mechanisms responsible for the interplay between NF-κB nuclear translocation and mitochondrial expression of TSPO. We compare epithelial human breast cancer MCF-7 cells which features low TSPO levels and a more aggressive counterpart MDA-MB-231 (henceforth referred to as MDA) derived from breast cancer adenocarcinoma which instead express high levels of TSPO 3 (Figure 1g-i) . In MDA, TSPO was then knocked down (SFigure 1b) before exposing the cohorts of cells (with high and low TSPO) to Staurosporine (STS), used here as a mitochondrial stressor/apoptotic stimulus, and we observed an increase in TSPO expression as a reaction to the stressor MCF-7 cells, which constitutively express lower TSPO levels, gain resistance to STSInduced apoptosis, when the gene is overexpressed but solely when the recombinant wildtype isoform of the protein is inserted, whereas, the mutant lacking the Cholesterol Binding Domain CRAC (TSPO∆CRAC) fails confer this resistance (Figure 3a-c ) present a high expression of TSPO (Figure 3d, e) . On the basis of this evidence we investigated whether pharmacological targeting of TSPO with FGIN-127 ligand could affect the nuclear pattern of the ERa in MCF7-LTED and their susceptibility to STS induced cell death. In both these parameters, the ligands was effective resulting in reducing ERa association with the nucleus (Figure 3g ) and higher cell death (Figure 3h) . Aligning with these observations, big-data analysis revealed that TSPO is over-expressed in cohorts of relapsed patients in whom endocrine therapy was no longer effective and cholesterol metabolism is escalated.
( Supplementary Figure 3 a) .
Following co-immunocytochemical labelling of TSPO and the nuclear envelope protein We have ascertained such a change in shortening of the distance between mitochondria and the nucleus of 4.3µm (please refer to Table 1 Reducing the distance between mitochondria and nucleus could be important to other signalling effectors downstream of impaired redox-stress and cholesterol metabolism.
Localized pools of ROS on the nucleus may lead to greater oxidation of the cholesterol tethered by TSPO, thus establishing a relay between TSPO, cholesterol and ROS via the generation of oxysterols that underlie various conditions including malignant proliferation 37, 38 .
In keeping with this, exposure of MDA to 7-ketocholesterol (7 KC) (which is the second most abundant oxysterol found in mammals) increases TSPO expression ( 4n ) (which can be estimated based on their diffusion co-efficient 41 ) prevents these reactive species from causing excessive damage or uncontrolled signalling in steady state. However, the formation of NAM, by bringing mitochondria within angstroms range with the nuclear DNA, will facilitate the efficient transmission of these molecules 36 . NAM will equally benefit the stabilization in the nucleus of transcriptional factor such as NF-κB 11 boosting the transcription of the regulated pro-survival genes. In this manner, NAM may represent a defensive mechanism in response to apoptotic cues in the short term, whilst long-term exposure of the nucleus to free radicals, will compromise DNA integrity leading to genomic alterations. This ties well into observations that cytoskeletal reorganization and cellular morphology are key factors in determining the cellular resistance to apoptosis as well as in regulating the NF-κB led signalling 42, 43 . Equally, nuclear pleomorphism of tumours which is proposed as a biomarker of malignancy for breast cancer 44 , could be due to the continuous exploitation of this mechanism thus resulting in resistance generating somatic mutations.
We report that in response to pro-apoptotic stressors mitochondria re-organise and 
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Methods
Immunohistochemistry/Immunocytochemistry: Immunofluorescence: Cells were fixed in 4% PFA (10 mins, RT) followed by 3 five-minute washes in PBS. Permeabilization was performed with 0.5% Triton-X in PBS (10 mins, RT) followed by washing. Blocking was carried out for 1h at RT in 10% Goat Serum and 3% BSA in PBS. Primary antibody incubations were conducted overnight for 16 h at 4˚C in blocking solution as described.
After a further wash step, secondary antibodies were incubated for 1 h in blocking solution, before a final wash step. Cells were then mounted on slides with DAPI mounting medium Cells were transiently transfected with genes of interest or siRNA using a standard Ca 2+ phosphate method as described previously 45 or using manufacturers' instructions for Lipofectamine 3000 (Thermofisher 18324010).
Cell Fractionation: Cells were lysed in cold isotonic buffer (250 mM Sucrose, 10 mM KCl, The infiltrate analysis was done using orthogonal rendering 3D optical stacks and counting the number of infiltrates per cell nucleus. The mitochondrial network analysis was performed using the 'skeletonize' plugin.
Cell Proliferation assays:
Cell proliferation assay were performed using the WST-1 Cell Proliferation Assay Kit (ab65473) and assessed on a standard plate reader (Tecan
SUNRISE)
Cell Death Assays: Cells were fixed in 4% PFA for 10 mins at, RT followed by 3 fiveminute washes in PBS. Permeabilization was performed with 0.2% Triton-X100 in PBS for 10 mins at RT followed by washing. Death assays TUNEL Assay Kit -in situ Direct DNA Ultrathin sections (70-90 nm thick) were cut using a Leica EM FC6 cryo-ultramicrotome and mounted on pioloform film-supported nickel grids according to the Tokuyasu method (1).
Sections were immunolabeled using anti-TSPO (Abcam, ab109497) (1:200) followed by a 12nm-colloidal gold anti-rabbit secondary antibody (Jackson ImmunoResearch) (1:40). Grids were examined at 120 kV on a JEOL JEM-1400Plus TEM fitted with a Ruby digital camera (2kx2k). TM1  TM2  TM3  TM5  TM4   CARC   CRAC   TM1  TM2  TM3   CARC   TM5  TM4   TM1  TM2  TM3  TM4  TM5   TSPO ΔCRAC   TSPO 
